Metric Finance
LearnFAQ
LearnFAQ

Learn / PAHC

NASDAQ: PAHC

Phibro Animal Health (PAHC) stock, explained like you're 5

Phibro Animal Health trades on the Nasdaq under the ticker PAHC. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.6 billion dollars.

Ticker
PAHC
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.6 billion dollars

Is Phibro Animal Health a small, medium or large cap company?

No. Phibro Animal Health is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.6 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Phibro Animal Health makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves PAHC stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Phibro Animal Health Corporatio (PAHC) Stock Forecasts (Yahoo Finance)
  • PAHC vs. HAE: Which Stock Is the Better Value Option? (Yahoo Finance)
  • What Is Drawing Attention To Phibro Animal Health (PAHC) Today? (Yahoo Finance)
  • Is it the Right Time to Add Phibro Stock to Your Portfolio? (Yahoo Finance)
  • Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain? (Yahoo Finance)

Follow PAHC in your daily brief

Each trading day at 5 PM ET we post what happened to Phibro Animal Health and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow PAHC

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Phibro Animal Health stock

What does Phibro Animal Health do?

Phibro Animal Health trades on the Nasdaq under the ticker PAHC. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.6 billion dollars.

What is the ticker symbol for Phibro Animal Health?

Phibro Animal Health trades under the ticker PAHC on the Nasdaq.

What is Phibro Animal Health's market cap?

Phibro Animal Health is a small cap stock with a market cap of about 1.6 billion dollars.

How does Phibro Animal Health make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves PAHC stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow PAHC stock every day?

Add PAHC to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow PAHC daily

A free brief on Phibro Animal Health and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare PAHC: PAHC vs NVS, PAHC vs AZN, PAHC vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed